News Devonian Health Group Inc.

Equities

GSD

CA2518341078

Market Closed - Toronto S.E. Other stock markets 03:01:37 2024-04-23 pm EDT			5-day change	1st Jan Change
0.22 ^CAD	0.00%		0.00%	+51.72%

Mar. 28	Devonian Health Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
Mar. 14	Devonian Health Group Closes Non-Brokered Private Placement; Down Nearly 7%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Devonian Health Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Mar. 28	CI
Devonian Announces Closing of a Private Placement of Units	Mar. 15	AQ
Devonian Health Group Closes Non-Brokered Private Placement; Down Nearly 7%	Mar. 14	MT
Devonian Health Group Inc. announced that it has received CAD 0.2238 million in funding	Mar. 12	CI
DEVONIAN HEALTH NAMES KATHRYN J. GREGORY TO THE BOARD OF DIRECTORS AND GRANTS STOCK OPTIONS	Mar. 01	AQ
Devonian Health Group Inc. Appoints Kathryn J. Gregory to the Board	Feb. 29	CI
Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole in Canada	Feb. 28	AQ
Devonian Announces $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan	Feb. 26	CI
DEVONIAN BOLSTERS INTELLECTUAL PROPERTY WITH ISSUANCE OF U.S. PATENT COVERING A METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE	Feb. 21	AQ
Devonian Health Group Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	Dec. 22	CI
DEVONIAN BOLSTERS LEADERSHIP TEAM AND ALIGNS STRATEGY TO ACCELERATE CLINICAL DEVELOPMENT AND DRIVE REVENUE GROWTH AND COMMERCIAL SUCCESS	Dec. 05	AQ
Devonian Health Group Inc. Announces CEO Changes	Dec. 04	CI
Devonian Health Group Inc. Announces Changes to its Board	Dec. 04	CI
Devonian Health Group Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	Nov. 28	CI
Devonian Health Group Inc. Files Patent Cooperation Treaty Application for Thykamine?? in Wound Healing	Nov. 08	CI
Devonian Health Group Inc. announced that it has received CAD 0.5 million in funding	23-08-31	CI
Devonian Health Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-28	CI
Devonian Health Group receives a Notice of Allowance for Issuance of a U.S. Patent on a method of treatment of Inflammatory Bowel Disease	23-06-21	AQ
Devonian Health Group Inc. announced that it has received CAD 1.199665 million in funding	23-06-05	CI
Devonian Health Group Plans to Raise Up To $5 Million via Private Placement	23-05-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Devonian Health Group Inc.

Equities

GSD

CA2518341078

Summary

Filters